CN Stock MarketDetailed Quotes

603168 Zhejiang Shapuaisi Pharmaceutical

Watchlist
  • 8.87
  • -0.11-1.22%
Market Closed May 17 15:00 CST
3.36BMarket Cap466.84P/E (TTM)

Zhejiang Shapuaisi Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-15.02%137.83M
17.37%644.97M
20.36%498.79M
21.94%341.55M
8.59%162.2M
-12.74%549.54M
-12.41%414.41M
-11.57%280.09M
-2.48%149.37M
75.80%629.76M
Operating revenue
-15.02%137.83M
17.37%644.97M
20.36%498.79M
21.94%341.55M
8.59%162.2M
-12.74%549.54M
-12.41%414.41M
-11.57%280.09M
-2.48%149.37M
75.80%629.76M
Other operating revenue
----
-29.03%6.94M
----
-8.62%4.42M
----
351.89%9.77M
----
-17.35%4.83M
----
5.51%2.16M
Total operating cost
2.91%133.51M
25.23%629.24M
19.66%443.24M
12.47%279.08M
1.34%129.73M
-13.41%502.47M
-13.07%370.41M
-11.95%248.13M
-6.17%128.01M
29.87%580.28M
Operating cost
-8.10%67.08M
24.59%283.93M
27.09%219.84M
29.27%146.66M
33.62%72.99M
1.44%227.89M
3.78%172.97M
-11.38%113.45M
-5.31%54.63M
21.95%224.67M
Operating tax surcharges
-27.61%1.43M
35.93%8.08M
1.17%4.73M
-0.79%3.24M
15.67%1.98M
-27.86%5.94M
-23.11%4.67M
-14.54%3.27M
-11.70%1.71M
44.16%8.24M
Operating expense
24.55%21.78M
45.09%135.33M
-5.86%71.2M
-16.33%38.95M
-33.54%17.48M
-19.84%93.28M
-7.19%75.63M
-19.70%46.56M
-28.81%26.31M
-21.97%116.36M
Administration expense
10.46%30.61M
16.47%136.27M
22.27%96.47M
13.91%62.69M
9.52%27.71M
-12.02%117M
-17.64%78.9M
-4.89%55.04M
-14.50%25.3M
53.06%132.98M
Financial expense
175.51%482.45K
194.82%1.19M
116.86%155.33K
-166.75%-811.09K
-14.03%-638.92K
70.09%-1.25M
77.70%-921.06K
89.18%-304.07K
59.86%-560.29K
39.66%-4.18M
-Interest expense (Financial expense)
--1.21M
180.86%4.61M
----
----
----
113.86%1.64M
----
----
----
--768.09K
-Interest Income (Financial expense)
-0.49%-948.45K
-20.30%-3.7M
-14.95%-2.59M
-88.78%-2.25M
1.64%-943.86K
39.15%-3.08M
50.57%-2.26M
58.70%-1.19M
33.73%-959.62K
28.97%-5.06M
Research and development
18.88%12.13M
8.11%64.45M
29.85%50.85M
-5.91%28.34M
-50.53%10.2M
-41.68%59.61M
-51.19%39.16M
-18.44%30.12M
77.11%20.62M
267.66%102.21M
Credit Impairment Loss
214.13%558.57K
171.51%3.09M
354.26%3.6M
595.49%3.02M
-19.95%-489.42K
-151.37%-4.32M
-1,938.75%-1.41M
-278.38%-609.77K
-970.29%-408.01K
-884.46%-1.72M
Asset Impairment Loss
190.31%310.46K
-27.97%-14.52M
228.63%950.75K
275.59%1.19M
---343.77K
-472.12%-11.34M
82.74%-739.15K
107.38%315.98K
----
98.36%-1.98M
Other net revenue
257.35%1.69M
-26.25%6.31M
12.10%19.23M
-65.45%5.29M
-107.35%-1.08M
57.40%8.56M
15,522.46%17.16M
1,128.69%15.3M
1,359.01%14.65M
104.91%5.44M
Fair value change income
---34K
-87.16%1.19M
15.36%431.96K
26.32%431.96K
----
251.42%9.27M
--374.46K
--341.96K
----
--2.64M
Invest income
143.20%172.04K
694.21%13.71M
660.95%13.9M
122.68%341.53K
52.49%-398.2K
-150.49%-2.31M
-33.27%1.83M
-158.77%-1.51M
-188.95%-838.11K
-40.95%4.57M
-Including: Investment income associates
452.78%444.2K
228.00%2.79M
--4.16M
--1M
--80.36K
---2.18M
----
----
----
----
Asset deal income
--17.79K
-99.68%51.04K
-99.84%25.41K
-99.95%7.81K
----
217,692.60%15.86M
220,570.31%16.07M
83,525.33%16.07M
--15.88M
98.69%-7.29K
Other revenue
333.05%669.43K
99.86%2.79M
-68.36%328.88K
-57.16%298.38K
1,624.16%154.59K
-28.04%1.4M
-40.02%1.04M
68.34%696.59K
-91.25%8.97K
-32.60%1.94M
Operating profit
-80.83%6.02M
-60.38%22.04M
22.28%74.79M
43.35%67.76M
-12.80%31.39M
1.27%55.62M
29.87%61.16M
41.36%47.27M
102.98%36M
127.54%54.92M
Add:Non operating Income
707.66%8.09K
147,289.18%15.04M
352,749.99%14.84M
673,707,690.91%14.82M
-87.79%1K
-80.74%10.21K
-84.17%4.2K
-99.99%2.2
-72.41%8.2K
-99.80%52.99K
Less:Non operating expense
-91.75%184.11K
147.24%4M
454.75%2.73M
719.69%2.64M
801.99%2.23M
-73.46%1.62M
-88.23%491.34K
-70.87%321.51K
-24.86%247.43K
105.73%6.1M
Total profit
-79.97%5.84M
-38.76%33.08M
43.22%86.9M
70.29%79.95M
-18.45%29.16M
10.51%54.01M
41.28%60.67M
45.08%46.95M
105.10%35.76M
127.69%48.87M
Less:Income tax cost
-76.49%1.6M
-13.89%7.97M
-50.05%7.7M
-39.91%6.8M
-16.31%6.79M
-29.94%9.26M
126.77%15.41M
109.33%11.32M
16.72%8.11M
361.59%13.22M
Net profit
-81.03%4.25M
-43.90%25.1M
74.99%79.2M
105.29%73.15M
-19.08%22.38M
25.51%44.75M
25.21%45.26M
32.19%35.63M
163.64%27.65M
FLtoP35.66M
Net profit from continuing operation
-81.03%4.25M
-45.18%25.1M
70.33%79.2M
98.40%73.15M
-22.54%22.38M
-9.19%45.79M
28.63%46.5M
36.78%36.87M
175.44%28.89M
191.72%50.43M
Net income from discontinuing operating
----
----
----
----
----
92.96%-1.04M
---1.24M
---1.24M
---1.24M
88.13%-14.77M
Less:Minority Profit
65.78%-51.05K
-35,333.41%-303.41K
---249.14K
---199.17K
---149.19K
--861.13
----
----
----
----
Net profit of parent company owners
-80.93%4.3M
-43.23%25.41M
75.54%79.45M
105.85%73.35M
-18.54%22.53M
25.51%44.75M
25.21%45.26M
32.19%35.63M
163.64%27.65M
119.88%35.66M
Earning per share
Basic earning per share
-83.33%0.01
-50.00%0.07
50.00%0.21
81.82%0.2
-33.33%0.06
27.27%0.14
27.27%0.14
37.50%0.11
200.00%0.09
119.64%0.11
Diluted earning per share
-83.33%0.01
-50.00%0.07
50.00%0.21
81.82%0.2
-33.33%0.06
27.27%0.14
27.27%0.14
37.50%0.11
200.00%0.09
119.64%0.11
Other composite income
Total composite income
-81.03%4.25M
-43.90%25.1M
74.99%79.2M
105.29%73.15M
-19.08%22.38M
25.51%44.75M
25.21%45.26M
32.19%35.63M
163.64%27.65M
119.88%35.66M
Total composite income of parent company owners
-80.93%4.3M
-43.23%25.41M
75.54%79.45M
105.85%73.35M
-18.54%22.53M
25.51%44.75M
25.21%45.26M
32.19%35.63M
163.64%27.65M
119.88%35.66M
Total composite income of minority owners
65.78%-51.05K
-35,333.41%-303.41K
---249.14K
---199.17K
---149.19K
--861.13
----
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -15.02%137.83M17.37%644.97M20.36%498.79M21.94%341.55M8.59%162.2M-12.74%549.54M-12.41%414.41M-11.57%280.09M-2.48%149.37M75.80%629.76M
Operating revenue -15.02%137.83M17.37%644.97M20.36%498.79M21.94%341.55M8.59%162.2M-12.74%549.54M-12.41%414.41M-11.57%280.09M-2.48%149.37M75.80%629.76M
Other operating revenue -----29.03%6.94M-----8.62%4.42M----351.89%9.77M-----17.35%4.83M----5.51%2.16M
Total operating cost 2.91%133.51M25.23%629.24M19.66%443.24M12.47%279.08M1.34%129.73M-13.41%502.47M-13.07%370.41M-11.95%248.13M-6.17%128.01M29.87%580.28M
Operating cost -8.10%67.08M24.59%283.93M27.09%219.84M29.27%146.66M33.62%72.99M1.44%227.89M3.78%172.97M-11.38%113.45M-5.31%54.63M21.95%224.67M
Operating tax surcharges -27.61%1.43M35.93%8.08M1.17%4.73M-0.79%3.24M15.67%1.98M-27.86%5.94M-23.11%4.67M-14.54%3.27M-11.70%1.71M44.16%8.24M
Operating expense 24.55%21.78M45.09%135.33M-5.86%71.2M-16.33%38.95M-33.54%17.48M-19.84%93.28M-7.19%75.63M-19.70%46.56M-28.81%26.31M-21.97%116.36M
Administration expense 10.46%30.61M16.47%136.27M22.27%96.47M13.91%62.69M9.52%27.71M-12.02%117M-17.64%78.9M-4.89%55.04M-14.50%25.3M53.06%132.98M
Financial expense 175.51%482.45K194.82%1.19M116.86%155.33K-166.75%-811.09K-14.03%-638.92K70.09%-1.25M77.70%-921.06K89.18%-304.07K59.86%-560.29K39.66%-4.18M
-Interest expense (Financial expense) --1.21M180.86%4.61M------------113.86%1.64M--------------768.09K
-Interest Income (Financial expense) -0.49%-948.45K-20.30%-3.7M-14.95%-2.59M-88.78%-2.25M1.64%-943.86K39.15%-3.08M50.57%-2.26M58.70%-1.19M33.73%-959.62K28.97%-5.06M
Research and development 18.88%12.13M8.11%64.45M29.85%50.85M-5.91%28.34M-50.53%10.2M-41.68%59.61M-51.19%39.16M-18.44%30.12M77.11%20.62M267.66%102.21M
Credit Impairment Loss 214.13%558.57K171.51%3.09M354.26%3.6M595.49%3.02M-19.95%-489.42K-151.37%-4.32M-1,938.75%-1.41M-278.38%-609.77K-970.29%-408.01K-884.46%-1.72M
Asset Impairment Loss 190.31%310.46K-27.97%-14.52M228.63%950.75K275.59%1.19M---343.77K-472.12%-11.34M82.74%-739.15K107.38%315.98K----98.36%-1.98M
Other net revenue 257.35%1.69M-26.25%6.31M12.10%19.23M-65.45%5.29M-107.35%-1.08M57.40%8.56M15,522.46%17.16M1,128.69%15.3M1,359.01%14.65M104.91%5.44M
Fair value change income ---34K-87.16%1.19M15.36%431.96K26.32%431.96K----251.42%9.27M--374.46K--341.96K------2.64M
Invest income 143.20%172.04K694.21%13.71M660.95%13.9M122.68%341.53K52.49%-398.2K-150.49%-2.31M-33.27%1.83M-158.77%-1.51M-188.95%-838.11K-40.95%4.57M
-Including: Investment income associates 452.78%444.2K228.00%2.79M--4.16M--1M--80.36K---2.18M----------------
Asset deal income --17.79K-99.68%51.04K-99.84%25.41K-99.95%7.81K----217,692.60%15.86M220,570.31%16.07M83,525.33%16.07M--15.88M98.69%-7.29K
Other revenue 333.05%669.43K99.86%2.79M-68.36%328.88K-57.16%298.38K1,624.16%154.59K-28.04%1.4M-40.02%1.04M68.34%696.59K-91.25%8.97K-32.60%1.94M
Operating profit -80.83%6.02M-60.38%22.04M22.28%74.79M43.35%67.76M-12.80%31.39M1.27%55.62M29.87%61.16M41.36%47.27M102.98%36M127.54%54.92M
Add:Non operating Income 707.66%8.09K147,289.18%15.04M352,749.99%14.84M673,707,690.91%14.82M-87.79%1K-80.74%10.21K-84.17%4.2K-99.99%2.2-72.41%8.2K-99.80%52.99K
Less:Non operating expense -91.75%184.11K147.24%4M454.75%2.73M719.69%2.64M801.99%2.23M-73.46%1.62M-88.23%491.34K-70.87%321.51K-24.86%247.43K105.73%6.1M
Total profit -79.97%5.84M-38.76%33.08M43.22%86.9M70.29%79.95M-18.45%29.16M10.51%54.01M41.28%60.67M45.08%46.95M105.10%35.76M127.69%48.87M
Less:Income tax cost -76.49%1.6M-13.89%7.97M-50.05%7.7M-39.91%6.8M-16.31%6.79M-29.94%9.26M126.77%15.41M109.33%11.32M16.72%8.11M361.59%13.22M
Net profit -81.03%4.25M-43.90%25.1M74.99%79.2M105.29%73.15M-19.08%22.38M25.51%44.75M25.21%45.26M32.19%35.63M163.64%27.65MFLtoP35.66M
Net profit from continuing operation -81.03%4.25M-45.18%25.1M70.33%79.2M98.40%73.15M-22.54%22.38M-9.19%45.79M28.63%46.5M36.78%36.87M175.44%28.89M191.72%50.43M
Net income from discontinuing operating --------------------92.96%-1.04M---1.24M---1.24M---1.24M88.13%-14.77M
Less:Minority Profit 65.78%-51.05K-35,333.41%-303.41K---249.14K---199.17K---149.19K--861.13----------------
Net profit of parent company owners -80.93%4.3M-43.23%25.41M75.54%79.45M105.85%73.35M-18.54%22.53M25.51%44.75M25.21%45.26M32.19%35.63M163.64%27.65M119.88%35.66M
Earning per share
Basic earning per share -83.33%0.01-50.00%0.0750.00%0.2181.82%0.2-33.33%0.0627.27%0.1427.27%0.1437.50%0.11200.00%0.09119.64%0.11
Diluted earning per share -83.33%0.01-50.00%0.0750.00%0.2181.82%0.2-33.33%0.0627.27%0.1427.27%0.1437.50%0.11200.00%0.09119.64%0.11
Other composite income
Total composite income -81.03%4.25M-43.90%25.1M74.99%79.2M105.29%73.15M-19.08%22.38M25.51%44.75M25.21%45.26M32.19%35.63M163.64%27.65M119.88%35.66M
Total composite income of parent company owners -80.93%4.3M-43.23%25.41M75.54%79.45M105.85%73.35M-18.54%22.53M25.51%44.75M25.21%45.26M32.19%35.63M163.64%27.65M119.88%35.66M
Total composite income of minority owners 65.78%-51.05K-35,333.41%-303.41K---249.14K---199.17K---149.19K--861.13----------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg